Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes.
Hoffmann L, Coras R, Kobow K, López-Rivera JA, Lal D, Leu C, Najm I, Nürnberg P, Herms J, Harter PN, Bien CG, Kalbhenn T, Müller M, Pieper T, Hartlieb T, Kudernatsch M, Hamer H, Brandner S, Rössler K, Blümcke I, Jabari S.
Hoffmann L, et al. Among authors: rossler k.
Acta Neuropathol. 2023 Jun;145(6):815-827. doi: 10.1007/s00401-023-02561-5. Epub 2023 Mar 27.
Acta Neuropathol. 2023.
PMID: 36973520
Free PMC article.